(Q38086010)

28 August 2017

MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells (English)

1 reference

28 August 2017

1 reference

neoplastic stem cells

1 reference

P Ceppi

1

1 reference

28 August 2017

M E Peter

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

4 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

33

1 reference

28 August 2017

269-278

1 reference

28 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.55

28 August 2017

0 references

cites work

EMT as the ultimate survival mechanism of cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells: impact, heterogeneity, and uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells: current status and evolving complexities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Induction and regulation of epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The tumor-suppressor function of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Regulation of vimentin by SIP1 in human epithelial breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Low frequency of E-cadherin alterations in familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Transcription and processing of human microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

microRNAs exhibit high frequency genomic alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The role of let-7 in cell differentiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Identification of let-7-regulated oncofetal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

HuR recruits let-7/RISC to repress c-Myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Lin28 promotes transformation and is associated with advanced human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer as an evolutionary and ecological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Breast tumor heterogeneity: cancer stem cells or clonal evolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells: mirage or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-34 miRNAs provide a barrier for somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Intact p53-dependent responses in miR-34-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-302-367 cluster as a potential stemness regulator in ESCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Eaten alive: a history of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Isolation and characterization of stem-like cells from a human ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Stem cell pathways contribute to clinical chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Isolation and characterization of spheroid cells from the HT29 colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cell markers in common cancers - therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells, microRNAs, and therapeutic strategies including natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Breast cancer stem cells: tools and models to rely on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

21 January 2018

Liver cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The transcriptome profile of human embryonic stem cells as defined by SAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Ovarian cancer stem cell markers: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cancer stem cells in nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

In vivo imaging, tracking, and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Side population cells in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

CD133 as a marker for cancer stem cells: progresses and concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Single-cell detection of microRNAs in developing vertebrate embryos after acute administration of a dual-fluorescence reporter/sensor plasmid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

A microRNA-based system for selecting and maintaining the pluripotent state in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Differentially expressed microRNAs in pancreatic cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.55

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.55

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference